A us distributor contacted zoll to report that a patient passed away on (b)(6) 2022 while reportedly wearing the lifevest.The device was started up at 23:19:53 on (b)(6) 2022.At 02:48:58 and 02:52:09 on (b)(6) 2022, an arrhythmia was detected two times.Ecg shows an idioventricular rhythm @ 30 bpm degrading to vf/fine vf with motion/tactile artifact and varying rates/amplitudes.The lifevest properly detected vf at 02:48:58 and 02:52:09 on (b)(6) 2022.Response button use, varying rates/amplitudes, and motion/tactile artifact prevent the lifevest from treating the patient.The device was shut down at 02:53:03 on (b)(6) 2022.
|
Device evaluation of the monitor and electrode belt has been completed.The evaluation included review of downloaded software flag files on the day of the event and incoming functional testing.During the incoming functional testing, a 1 hz simulated normal sinus rhythm signal was applied to the ecg electrodes, followed by a 5 hz simulated treatable arrhythmia signal which verified proper performance of the detection algorithm.During the transition to the 5 hz signal, the device was confirmed to properly enter into a treatment sequence which includes a verification of the tactile vibration alarm, audio messaging, and siren alarms, as well as a test of the pulse delivery circuitry.The pulse delivery circuitry test verified proper charging of the high voltage capacitors and proper delivery of five full energy 150j biphasic pulses.The functional testing confirmed proper response button functionality, ecg acquisition, detection algorithm performance, and pulse delivery functionality.There is no indication of a product malfunction.
|